New directions in the treatment of colorectal cancer: a look to the future (Q33875868)

29 July 2017

1 reference

title

New directions in the treatment of colorectal cancer: a look to the future (English)

1 reference

29 July 2017

1 reference

1 reference

3

Glimelius B

1 reference

29 July 2017

Sobrero A

1

1 reference

29 July 2017

Kerr D

2

1 reference

29 July 2017

Van Cutsem E

4

1 reference

29 July 2017

Milano G

5

1 reference

29 July 2017

Pritchard DM

6

1 reference

29 July 2017

Rougier P

7

1 reference

29 July 2017

Aapro M

8

1 reference

29 July 2017

1 March 2000

1 reference

European Journal of Cancer

29 July 2017

1 reference

29 July 2017

36

1 reference

29 July 2017

5

1 reference

29 July 2017

559-566

1 reference

Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

General condition of asymptomatic patients with advanced colorectal cancer receiving palliative chemotherapy. A longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

The relationship between an objective response to chemotherapy and survival in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

Superiority of sequential methotrexate, fluorouracil, and leucovorin to fluorouracil alone in advanced symptomatic colorectal carcinoma: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

Biochemical modulation of 5-fluorouracil: a randomized comparison of sequential methotrexate, 5-fluorouracil and leucovorin versus sequential 5-fluorouracil and leucovorin in patients with advanced symptomatic colorectal cancer. The Nordic Gastroint

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

Monitoring palliative chemotherapy in advanced gastrointestinal cancer using serial tissue polypeptide specific antigen (TPS) measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

Drug-target interactions: only the first step in the commitment to a programmed cell death?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

p53 protein overexpression and response to biomodulated 5-fluorouracil chemotherapy in patients with advanced colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

What is an apoptotic index measuring? A commentary

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

Apoptosis and gastrointestinal pharmacology.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

Clinical pharmacology of 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

Population study of dihydropyrimidine dehydrogenase in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

Pharmacokinetic, oral bioavailability, and safety study of fluorouracil in patients treated with 776C85, an inactivator of dihydropyrimidine dehydrogenase

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

Inhibition by uridine but not thymidine of p53-dependent intestinal apoptosis initiated by 5-fluorouracil: evidence for the involvement of RNA perturbation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

Fluorouracil in colorectal cancer--a tale of two drugs: implications for biochemical modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

Synergism and lack of cross-resistance between short-term and continuous exposure to fluorouracil in human colon adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

High-dose folinic acid, 5-fluorouracil bolus and continuous infusion in metastatic colorectal cancer: a 3-day/3-week schedule. Group d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

Biweekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, fluorouracil, and leucovorin in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

A glimpse of the future. new directions in the treatment of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

Phase I study of recombinant CEA vaccinia virus vaccine with post vaccination CEA peptide challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900314-7

7 January 2021

10.1016/S0959-8049(99)00314-7

Identifiers

DOI

1 reference

release_jolpgqm2gnd7rkaxmodlkzoo7m

29 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jolpgqm2gnd7rkaxmodlkzoo7m

24 November 2022

mapped directly with Wikidata item

1 reference